↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Monami M.) "

Sökning: WFRF:(Monami M.)

Resultat 1-3 av 3

Sortera/gruppera träfflistan

Sortering: Träffar per sida:

Numrering	Referens	Omslagsbild	Hitta
1.	Pinkney, T, et al. (författare) The relationship between method of anastomosis and anastomotic failure after right hemicolectomy and ileo-caecal resection: an international snapshot audit 2017 Ingår i: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. - : Wiley. - 1463-1318 .- 1462-8910. ; 19:8, s. O296-O311 Tidskriftsartikel (refereegranskat)
2.	Pinkney, T, et al. (författare) An international assessment of the adoption of enhanced recovery after surgery (ERAS®) principles across colorectal units in 2019-2020 2021 Ingår i: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. - : Wiley. - 1463-1318 .- 1462-8910. ; 23:11, s. 2980-2987 Tidskriftsartikel (refereegranskat)
3.	Monami, M., et al. (författare) Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials 2013 Ingår i: Diabetes, Obesity and Metabolism. - : Wiley. - 1462-8902. ; 15:2, s. 112-120 Tidskriftsartikel (refereegranskat)abstract Aims Preliminary data from randomized trials with metabolic outcomes have shown that treatment with dipeptidyl peptidase-4 inhibitors (DPP4i) could be associated with a reduced incidence of major cardiovascular events (MACE). The present meta-analysis is aimed at verifying this protective effect, collecting all available data from randomized trials. Methods A comprehensive search for published and unpublished trials with a duration =24 weeks comparing DPP4i with placebo or other drugs was performed, retrieving all MACE reported as serious adverse events together with death from any cause. MantelHaenzel odds ratio (MHOR) was calculated with random effect models for MACE, myocardial infarction, stroke and mortality. When available, effects on glycated haemoglobin, lipid profile and blood pressure were also assessed and used for the estimation of the modification of risk for myocardial infarction using the UKPDS risk engine. Results A total of 70 trials, enrolling 41?959 patients with a mean follow-up of 44.1 weeks, was collected and included in the analysis. The MHOR (95% Confidence Interval) was 0.71[0.59;0.86], 0.64[0.44;0.94], 0.77[0.48;1.24] and 0.60[0.41;0.88] for MACE, myocardial infarction, stroke and mortality, respectively. Conclusions Treatment with DPP4i reduces the risk of cardiovascular events (particularly myocardial infarction) and all-cause mortality in patients with type 2 diabetes. The reduction in the incidence of myocardial infarction is greater than what predicted on the basis of conventional risk factors, suggesting a role for other mechanisms.

Skapa referenser, mejla, bekava och länka

Länka till träfflistan

Resultat 1-3 av 3

Avgränsa träffmängd

Typ av publikation: tidskriftsartikel (3)

Typ av innehåll: refereegranskat (3)

Författare/redaktör: Rossi, E. (2); Sanchez, J. (2); Wang, X. (2); Davies, E (2); Alonso, J. (2); Abraham-Nordling, M (2); visa fler...; Garcia-Granero, E (2); Golda, T (2); Mikalauskas, S (2); Perry, R (2); Patel, P. (2); Sharma, A (2); Yamamoto, T. (2); Strupas, K (2); Leventoglu, S (2); Nepogodiev, D (2); Pata, F (2); Smart, N (2); Spinelli, A (2); Sokolov, M (2); Martinek, L (2); Cotte, E (2); Glehen, O (2); Hanly, A (2); Winter, D (2); Zmora, O (2); Bianco, F (2); Muratore, A (2); Belli, A (2); Scabini, S (2); La Torre, F (2); Mingoli, A (2); Konsten, J (2); Barisic, G (2); Krivokapic, Z (2); Kenic, M (2); Escartin, J (2); Frasson, M (2); Pellino, G (2); Tezas, S (2); Velchuru, V (2); Khan, J (2); Bhangu, A (2); Raymond, T (2); Singh, B (2); Branagan, G (2); Oshowo, A (2); Nygren, J (2); COSTA, S (2); Aslam, M. (2); visa färre...

Lärosäte: Lunds universitet (2); Karolinska Institutet (2); Uppsala universitet (1)

Språk: Engelska (3)

Forskningsämne (UKÄ/SCB): Medicin och hälsovetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - Nationella bibliotekssystem
LIBRIS.kb.se

pil uppåt

Stäng

Kopiera och spara länken för att återkomma till aktuell vy